Carmen Brace and Aclara Research publishes “largest study of Illinois patients” today; Brace will participate in Southeast Michigan Cannabis Business Development Conference on July 9
by Rick Thompson/March 23, 2017
CHICAGO– Aclara Research issued a press release today announcing the publication of their latest research study on cannabis use.
The Chicago-based research firm has completed The Illinois Medical Cannabis Patient Experience Study, defined as “the first (study) of Illinois patients since the inception of the pilot program in 2012.”
Some of the Study’s key findings include: 22% of respondents had not used cannabis before entering Illinois’ medical marijuana program; the Study identified key gender gaps within the system and among the patient community; 86% of patients reported suffering from chronic pain symptoms; 33% of patients surveyed stopped ALL prescription pill use after beginning medical marijuana use; 92% of all respondents reduced their prescription pill use; 49% of patients make less than $40,000 annually.
“The study is the largest and most comprehensive look at the impact of the statewide program, examining nearly 300 of the 18,000 Illinois residents registered,” per the group’s press release.
“We are excited to be the first to conduct the largest study of Illinois patients since the inception of the pilot program,” said Carmen Brace, Founder of Aclara Research, in the release. “We will continue to build strong partnerships within the state and other markets to provide our clients with insights that lead to consumer centric product innovation and business strategies across medical use markets.”
Brace will be speaking in Michigan during the Southeast Michigan Cannabis Business Development Conference on July 9 at the Atheneum Hotel in Detroit’s Greektown district. She will be participating in a panel discussion on Advancing Women in the Cannabis Industry.
Aclara Research published two research works in 2016. One was a study titled Medical Cannabis and Chronic Pain and the company’s website describes it as: “Explore the mindset of Michigan patients using cannabis to find relief from the leading symptoms of chronic pain conditions.” Read more about this study here.
A separate study published in 2016 is titled Cannabis Infused Product Usage, which is described as: “A deep dive into patient and consumer usage habits, product selection and media influencers within this high growth product segment across Michigan and Oregon.”
The results of these studies can be used to determine “consumer usage” and “spending behavior and the retail experience,” according to the Aclara Research website.